These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11553972)

  • 1. Parkinson's disease. The apoptosis hypothesis revisited.
    Hartmann A; Hirsch EC
    Adv Neurol; 2001; 86():143-53. PubMed ID: 11553972
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease. The apoptosis hypothesis.
    Stern G
    Adv Neurol; 1996; 69():101-7. PubMed ID: 8615116
    [No Abstract]   [Full Text] [Related]  

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.
    Hartmann A; Hunot S; Hirsch EC
    Exp Neurol; 2003 Dec; 184(2):561-4. PubMed ID: 14769349
    [No Abstract]   [Full Text] [Related]  

  • 8. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide.
    Singh S; Dikshit M
    Brain Res Rev; 2007 Jun; 54(2):233-50. PubMed ID: 17408564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cells and abnormal protein handling in the pathogenesis of Parkinson's disease.
    McNaught KS; Lee M; Hyun DH; Jenner P
    Adv Neurol; 2001; 86():73-82. PubMed ID: 11554011
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
    Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL
    Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewy bodies in Parkinson's disease: protectors or perpetrators?
    Harrower TP; Michell AW; Barker RA
    Exp Neurol; 2005 Sep; 195(1):1-6. PubMed ID: 16023637
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease.
    Peng J; Andersen JK
    IUBMB Life; 2003; 55(4-5):267-71. PubMed ID: 12880208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.
    Huisman E; Uylings HB; Hoogland PV
    Mov Disord; 2008 Jul; 23(10):1407-13. PubMed ID: 18581481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease. Signs of disease in fetal transplants.
    Miller G
    Science; 2008 Apr; 320(5873):167. PubMed ID: 18403684
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuronal pathology in Parkinson's disease.
    Schulz JB; Falkenburger BH
    Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nondopaminergic neurons in Parkinson's disease.
    Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
    Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
    [No Abstract]   [Full Text] [Related]  

  • 18. Causes of neuronal death in Parkinson's disease.
    Schapira AH
    Adv Neurol; 2001; 86():155-62. PubMed ID: 11553973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of electroacupuncture on behaviors and dopaminergic neurons in the rat of Parkinson's disease].
    Ma J; Wang YC; Gan SY
    Zhongguo Zhen Jiu; 2006 Sep; 26(9):655-7. PubMed ID: 17036487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous regeneration in Parkinson's disease: do we need orthotopic dopaminergic neurogenesis?
    Hermann A; Storch A
    Stem Cells; 2008 Nov; 26(11):2749-52. PubMed ID: 18719222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.